In 56 CMML patients, 25% (14/56) of patients were found to have SRSF2 mutations (P95H (11 patients), P95L (1 patient), P95R (1 patient) and P95fs*19 (1 patient)) (Figure 1B). This evidence concerns the gene SRSF2 and chronic myelomonocytic leukemia.